Greetings!

By delivering this special New Year Edition of the OncoWuXi Newsletter, we would like to extend our sincere appreciation for your continued interest in OncoWuXi database, and wish you a happy, healthy and prosperous New Year! This Special Edition will bring you our full year database overview on target identification and validation, biomarker, targeted oncology, immuno-oncology, and immunology platforms.

It has been our pleasure to collaborate with you throughout the year and with a deep gratitude for your continued trust and support, we look forward to serving you again in 2020!

.. Target Identification and Validation .

  • Target identification by in vitro & in vivo CRISPR library screening
  • Genome-wide library and customized library
  • Target gene knockout or knockin via CRISPR/Cas9
  • Cell line engineering for target gene overexpression and knockdown
  • Genetically engineered animal model
。。...。 Biomarker Platform 。 .。.......

  • Phenotypic analysis of tumor infiltrating leukocytes with FACS
  • In vivo phosphor flow cytometry analysis
  • High-throughput MSD and multiplex Luminex assay
  • Multiplex IHC, IF, RNAscope staining
  • Nanostring
  • CAP accredited and GCP compliant clinical biomarker analysis with FACS and IHC, IF, etc. 
。...... Targeted Oncology Platform 。....

  • 203 CDX models
  • 1200+ PDX models
  • Induced drug resistant models
  • Genetically engineered Ba/F3 models
。...... Immuno-Oncology Platform 。....

  • 61 syngeneic tumor models
  • Human immune checkpoint and co-stimulatory molecules KI syngeneic tumor models
  • Human PBMCs humanized xenograft models
  • Checkpoint inhibitor validation and immune profiling
。。...... Immunology  Platform 。.....。..

  • Autoimmune & inflammatory disease animal models
  • In vitro/Ex vivo immunology assays